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HIV-associated immune complex glomerulonephritis with
“lupus-like” features: A clinicopathologic study of 14 cases.
Background. While the most common glomerular lesion
associated with human immunodeficiency virus (HIV) infec-
tion is collapsing focal segmental glomerulosclerosis (FSGS)
[HIV-associated nephropathy (HIVAN)], immune complex-
mediated forms of glomerulonephritis have been increasingly
reported. One form of glomerulonephritis that has been de-
scribed in the HIV-infected population is immune complex
glomerulonephritis with “lupus-like” features, characterized by
histologic, immunohistologic, and ultrastructural features re-
sembling lupus nephritis, but occurring in patients without evi-
dence of systemic lupus erythematosus (SLE). Data regarding
clinical outcomes in patients with this form of glomerulonephri-
tis are very limited.
Methods. We reviewed pathology reports for all native renal
biopsy specimens from HIV-positive patients processed at our
center from January 1999 through December 2003. Of 77 total
specimens, 14 met the following criteria for lupus-like glomeru-
lonephritis: (1) immunofluorescence microscopy showed gran-
ular glomerular staining for IgG, IgA, IgM, C3 and C1q, with
≥1+ (0 to 4+ scale) staining for C1q; and (2) the patient’s serum
was negative for antinuclear antibodies (ANA), or weakly posi-
tive (titer ≤1:80) for ANA and negative for antidouble-stranded
DNA.
Results. Clinically, ten of the 14 patients with lupus-like
glomerulonephritis presented with nephrotic syndrome, all had
microscopic hematuria, and nine had serum creatinine >3.0
mg/dL. All but one were African American. Histologically,
seven biopsies showed diffuse proliferative glomerulonephri-
tis, six focal proliferative glomerulonephritis, and one membra-
nous nephropathy. All but two biopsies showed moderate or se-
vere chronic change, and three showed concurrent HIVAN. Ten
of the 14 patients developed end-stage renal disease (ESRD)
within 1 year of the biopsy. Nine of these ten patients presented
with proteinuria >5.0 g/24 hours and nephrotic syndrome, while
three of four patients who did not develop ESRD had protein-
uria ≤3.0 g/24 hours.
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Conclusion. Lupus-like glomerulonephritis, defined by im-
munohistologic features and absence of serologic evidence of
SLE, is not an uncommon form of glomerular disease in HIV-
infected patients undergoing a renal biopsy. Renal outcomes in
these patients were poor, although this may be due largely to
most patients presenting with advanced disease.
While the most common glomerular lesion associ-
ated with human immunodeficiency virus (HIV) infec-
tion is focal segmental glomerulosclerosis (FSGS), par-
ticularly the collapsing variant with marked associated
tubulointerstitial changes [HIV-associated nephropa-
thy (HIVAN)], immune complex-mediated glomeru-
lonephritides have become increasingly recognized in
HIV-positive patients [1–6]. The latter lesions in-
clude postinfectious glomerulonephritis, membranous
nephropathy, IgA nephropathy, fibrillary glomeru-
lonephritis, immunotactoid glomerulopathy, and mem-
branoproliferative glomerulonephritis (MPGN) [1–5],
the latter most often in patients coinfected with hepatitis
C virus [7, 8]. HIVAN, like primary FSGS and particu-
larly collapsing FSGS not related to HIV, has a strong
predilection for patients of black race [1, 2, 9–12]. By
contrast, immune complex glomerulonephritis in HIV-
infected patients has been reported mainly in white and
Asian patients [2–4], although such lesions may occur in
black patients as well, in some instances concomitantly
with HIVAN [2].
One form of immune complex glomerulonephritis that
has been described in the HIV-infected population is
immune complex glomerulonephritis with “lupus-like”
features, characterized by a “full house” pattern of im-
munoglobulin (IgG, IgA, and IgM) and complement
(C3 and C1q) deposits within the glomeruli, often with
large subendothelial deposits (“wire loops”). However,
unlike HIV-infected patients with lupus nephritis [13–
17], patients with lupus-like glomerulonephritis lack both
serologic and clinical evidence of systemic lupus ery-
thematosus (SLE). Nochy et al [2] reported that 22
(37%) of 60 French HIV-positive patients who under-
went a renal biopsy had some form of immune complex
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glomerulonephritis, with or without concurrent HIVAN,
and ten of these 22 biopsies showed histologic, im-
munofluorescence, and electron microscopic features re-
sembling diffuse proliferative lupus nephritis. Two of
the biopsies showed concurrent HIVAN. Six of the ten
patients were black and four were white, and none
had positive lupus serologies, although these were not
tested for in all patients [2]. Casanova et al [3] re-
ported results from renal biopsies performed in 26
Italian HIV-positive patients, all white. Twenty of these
patients had immune complex glomerulonephritis, none
had HIVAN. Three of the 20 cases with immune com-
plex deposits showed proliferative glomerulonephritis
with lupus-like features, with subendothelial deposits in
all three cases and hyaline thrombi and “wire loops” in
two, although immunofluorescence studies were not done
in one case. Antinuclear antibodies (ANA) were absent
in those two cases where these were tested. In a series
of consecutive renal biopsies from 136 predominantly
African-American HIV-positive patients from New York
City, D’Agati and Appel [1] found four cases of lupus-like
glomerulonephritis.
Very limited information is presently available regard-
ing treatment of and clinical outcomes in patients with
lupus-like glomerulonephritis. Tabechian et al [18] re-
cently reported a case of a 42-year-old HIV-positive white
man who presented with nephrotic syndrome and renal
insufficiency, who had two renal biopsies showing dif-
fuse proliferative glomerulonephritis resembling World
Health Organization (WHO) class IV lupus nephritis,
but who had negative lupus serologies. His renal func-
tion remained stable while he received highly active an-
tiretroviral therapy (HAART), but rapidly deteriorated
to end-stage renal disease (ESRD) during an interval
when HAART was discontinued and his HIV viral load
increased.
In this paper, we present 14 cases of lupus-like glomeru-
lonephritis in HIV-positive patients, emphasizing the
morphologic features seen on renal biopsy as well as clin-
ical presentations and outcomes of these patients. All
14 biopsies showed a “full house” pattern of glomeru-
lar immunoglobulin (IgG, IgA, and IgM) and comple-
ment (C3 and C1q) deposits by immunofluorescence, and
each of the 12 biopsies examined by electron microscopy
showed subendothelial and mesangial immune com-
plex deposits, with subepithelial deposits in nine. Like
true lupus nephritis, these cases of lupus-like glomeru-
lonephritis showed a variety of histologic patterns, includ-
ing diffuse proliferative and focal proliferative glomeru-
lonephritis as well as membranous nephropathy without
glomerular proliferative changes. However, renal out-
comes were generally poor regardless of histologic pat-
tern and treatment given, perhaps in large part because
most of the patients presented with advanced disease with
renal biopsies showing extensive chronic changes.
METHODS
Computerized records of the Department of Pathol-
ogy, Johns Hopkins Hospital, were searched to identify
all native renal biopsy specimens received from HIV-
positive patients [with or without clinically evident ac-
quired immunodeficiency syndrome (AIDS)] from Jan-
uary 1999 through December 2003. Excluding repeat
biopsies, a total of 77 specimens were identified. We then
examined the pathology reports for each of these spec-
imens to identify those showing a “full house” pattern
of glomerular immunoglobulin (IgG, IgA, and IgM) and
complement (C3 and C1q) deposits by direct immunoflu-
orescence studies performed on cryostat sections of un-
fixed tissue. Only cases showing granular staining in the
glomerular capillary walls, mesangial areas, or both in all
glomeruli present (excluding globally sclerotic glomeruli)
with at least 1+ C1q staining on a 0 to 4+ scale of stain-
ing intensity were included; segmental, blotchy stain-
ing typical of hyalinosis lesions and nonspecific pseu-
dolinear staining of glomerular capillary loops were not
considered. For cases meeting these criteria, computer-
ized patient records and clinical data received with the
biopsy were examined to determine the results of tests
for lupus serologies including ANA, antidouble-stranded
DNA (anti-ds DNA), anti-Ro, anti-La, and anti-Smith
(anti-Sm). Inclusion in this study was limited to patients
with a negative ANA, or a weakly positive ANA (titer
≤1:80) with negative anti-ds DNA. A total of 14 patients
met all of these pathologic and serologic criteria for in-
clusion in the study; none of these patients had a positive
anti-ds DNA, anti-Ro, anti-La, or anti-Sm serologic test,
although all of these were not tested for in every patient.
For these 14 cases, the computerized patient records
and clinical data received with each of the 14 biopsy spec-
imens were re-examined, and questionnaires requesting
any information we sought (see below) that was not
present in these records as well as follow-up clinical data
were sent to the nephrologists caring for each patient. For
each patient, the following information was recorded on
spread sheets, identifying patients by only a study number
(1 to 14): patient gender, race, and age, serum creatinine,
24-hour urine protein, the presence or absence of hema-
turia (microscopic and gross), and the presence or ab-
sence of nephrotic syndrome, the latter five parameters at
the approximate time of the renal biopsy. Nephrotic syn-
drome was defined as proteinuria of at least 3.5 g/24 hours,
with edema. We also recorded the presence or absence
of hypertension (defined as systolic and diastolic blood
pressures ≥130 mm Hg and ≥90 mm Hg, respectively,
and/or treatment with antihypertensive medication), du-
ration of HIV infection at the time of the biopsy and risk
factors for HIV infection (e.g., intravenous drug abuse),
lupus serologies (ANA, anti-ds DNA, anti-Ro, anti-La,
and anti-Sm) and titers when positive, whether or not the
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serum C3 level was below the reference range, and the
presence or absence of hepatitis B surface antigen and
hepatitis C. Finally, we recorded the medications received
by each patient prior to and after the biopsy, whether each
patient developed ESRD requiring dialysis or died and
if so the number of months after the biopsy when these
events occurred, and for those patients who had not de-
veloped ESRD the number of months after the biopsy of
last follow-up, and the serum creatinine level at that time.
Examination of renal biopsies
Histologic slides from each biopsy, stained with hema-
toxylin and eosin, periodic acid-Schiff (PAS), silver
methenamine, and Masson’s trichrome stains, were ex-
amined by a renal pathologist (M.H.), blinded to the clin-
ical data. For each biopsy, the following information was
recorded on a second set of spread sheets, again using only
the study numbers (1 to 14) as identifiers: (1) histologic
type of glomerulonephritis (e.g., diffuse proliferative, fo-
cal proliferative, membranous), using the WHO classifi-
cation for lupus nephritis [19] to define each histologic
subtype (for diffuse proliferative glomerulonephritis, it
was also noted if the lesion showed a membranoprolif-
erative pattern, with diffuse endocapillary cell prolifer-
ation, hyperlobular glomeruli, and double contours of
the glomerular basement membranes on PAS and sil-
ver stains); (2) presence or absence of crescents, and if
present the fraction of glomeruli in which crescents were
seen, not including globally sclerotic glomeruli; (3) pres-
ence or absence of glomerular “wire loops; ” (4) the sever-
ity of tubulointerstitial scarring, estimated using the sil-
ver and trichrome stains as the percentage of the cortex,
exclusive of glomeruli and arteries, occupied by sclerotic
interstitium and atrophic tubules; and (5) presence of any
concurrent lesions, including HIVAN (global or segmen-
tal collapse of the tuft in at least one glomerulus, with
associated podocyte hyperplasia), thrombotic microan-
giopathy, or possible drug-induced interstitial nephritis,
defined as focally heavy interstitial lymphocytic or lym-
phoplasmacytic infiltrates containing eosinophils [≥5 per
high power (400×) field in one or more foci], located near
the corticomedullary junction and/or in nonscarred areas
of the cortex and/or outer medulla, and not directly adja-
cent to disrupted tubules containing proteinaceous casts.
Following this, the renal biopsy reports from these
14 cases were further reviewed and the following data
recorded on the spread sheets containing the histopatho-
logic findings: (1) the intensity (0 to 4+, in increments of
0.5+) of granular glomerular immunofluorescence stain-
ing for IgG, IgA, IgM, C3, C1q, kappa, and lambda, and
whether this staining was in capillary walls, mesangium,
or both; (2) if present, the location (e.g., tubular base-
ment membranes, peritubular capillaries, focal or diffuse)
and intensity of extraglomerular staining for any of the
immune reactants; and (3) for those 12 cases in which
electron microscopy was performed, the location (mesan-
gial, subendothelial, subepithelial, or intramembranous)
and relative amount of electron-dense deposits within
glomeruli, the location of any extraglomerular deposits
present, whether any of the deposits showed a specific
(e.g., fibrillar, fingerprint-like) substructure, and if tubu-
loreticular inclusions (TRIs) were present in endothelial
cell cytoplasm.
Electron micrographs from each biopsy were also re-
viewed and the findings compared with those described
in the biopsy reports. In none of the 12 cases in which
electron microscopy was performed were discrepancies
found with respect to location of electron-dense deposits
within or outside of glomeruli, presence or absence of
substructure within deposits, or presence or absence of
TRIs.
Data analysis
Clinical and pathologic data, with only the study num-
bers (1 to 14) as identifiers, were entered into an elec-
tronic database and the accuracy of data transcription was
independently confirmed. Outlying values were identi-
fied using box plots and their accuracy checked against the
original source data. Continuous data were summarized
using means and standard deviations (SD), and compared
using Mann-Whitney U tests. Categorical variables were
compared using the chi-square test.
Renal survival was measured from the time of biopsy
and was examined by time to event analysis using the
Kaplan-Meier method. Univariate associations between
clinical and pathologic parameters and renal survival
were performed using Cox regression analysis. All study
patients who died had ESRD requiring dialysis at the time
of death, and as such censoring of these patients was not
required. Analyses were performed using SPSS Base 7.5
(SPSS Inc., Chicago, IL, USA).
All study procedures were approved by the Institu-
tional Review Board of Johns Hopkins Hospital.
RESULTS
A total of 77 native renal biopsies from HIV-positive
patients, not including repeat biopsies, were evaluated at
our center from January 1999 through December 2003.
Primary renal biopsy diagnoses in all 77 patients, and
within different racial groups, are summarized in Table 1.
The most common diagnosis, accounting for 31 (40%)
of the cases, was HIVAN, which was seen exclusively in
African Americans. Twenty-six (34%) biopsies showed
immune complex glomerulonephritis; 85% of these pa-
tients were also African Americans and six had con-
current HIVAN. Only one patient had lupus nephritis
with serologic findings of SLE; this was a 10-year-old
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Table 1. Primary renal biopsy diagnoses in 77 human
immunodeficiency virus (HIV)-positive patients of different races
Number (%) of cases in
patients of indicated race
African
Diagnosis American White Asian All races
HIV-associated nephropathy 29 (43) 0 0 31 (40)a








9 (13) 2 (29) 1 (100) 12 (16)
Interstitial nephritis,
drug-induced
2 (3) 2 (29) 0 4 (5)
Thrombotic microangiopathy 1 (1) 0 0 1 (1)
Amyloidosis, type AA 1 (1) 0 0 1 (1)
Hypertensive nephrosclerosis 1 (1) 0 0 1 (1)
All cases 67 7 1 77a
% Total patients of known race 89% 9% 1%
aThe race of two patients is not known.
bThese diagnoses include IgA nephropathy (three cases), membranous
nephropathy (two cases), resolving postinfectious glomerulonephritis (two
cases), membranoproliferative glomerulonephritis type I (two cases), mem-
branoproliferative glomerulonephritis type III (one case), lupus nephritis (one
case), and mesangial proliferative glomerulonephritis with mesangial deposits
of IgM and C3 (one case). Other than the single case of lupus nephritis, none
of these biopsies showed a “full house” of glomerular immunoglobulin and
complement deposits as defined in the Methods section.
boy with congenital HIV, and ANA and anti-ds DNA
titers of 1:640 and 1:320, respectively. However, 14 (18%
of total) biopsies met our criteria for showing lupus-like
glomerulonephritis, namely showing a “full house” pat-
tern of glomerular immunoglobulin (IgG, IgA, and IgM)
and complement (C3 and C1q) deposits with at least 1+
staining intensity for C1q (0 to 4+ scale), with the patient
having a negative ANA or a weakly positive (titer <1:80)
ANA with negative anti-ds DNA. Demographic, clinical,
and serologic features of these 14 patients are listed in
Table 2. All but one of the patients were >28 years old
at the time of the renal biopsy; the one remaining patient
was a 10-year-old girl with neonatally acquired HIV. All
but one patient were African Americans, and in eight of
12 cases where this information was available patients
were known to be HIV-positive for at least 10 years prior
to the biopsy. The majority of patients presented with
severe renal insufficiency (serum creatinine >3.0 mg/dL
in nine of 14), heavy proteinuria (24-hour urine protein
>5.0 g in 10 of 14) and the nephrotic syndrome, and hy-
pertension; all had microscopic hematuria, although none
had gross hematuria. ANA was negative in 11 of the 14
patients; six of these patients also had testing done for
anti-ds DNA and in each case this was negative as well.
Three patients had weakly positive ANA (1:40 titer in one
patient and 1:80 in two) with negative anti-ds DNA and
anti-Sm; in two of these patients where tests were done
Table 2. Demographic, clinical, and serologic features of patients
with lupus-like glomerulonephritis
Age years (mean ± SD) 35.8 ± 9.2 (14)
Age years, range 10 to 47
Gender male/female 9/5
Race African American/white 13/1
Known duration of HIV years (mean ± SD) 10.3 ± 6.4 (12)
Known duration of HIV years, range 1 to 17
History of IVDA fraction (%) of patients 8/11 (73%)
Serum creatinine mg/dL (mean ± SD) 5.5 ± 4.3 (14)
Serum creatinine mg/dL range 0.7 to 16.0
Proteinuria g/24 hours (mean ± SD) 7.4 ± 7.3 (14)
Proteinuria g/24 hours, range 0.5 to 30.5
Nephrotic syndrome fraction (%) of patients 10/14 (71%)
Microscopic hematuria fraction (%) of patients 14/14 (100%)
Hypertension fraction (%) of patients 11/14 (79%)
Antinuclear antibodies negative/weakly positive 11/3
Hepatitis B surface antigen fraction (%) positive 1/10 (10%)
Hepatitis C fraction (%) positive 6/12 (50%)
Serum C3 normal/decreased 5/4
Numbers in parentheses without percent signs indicate numbers of patients.
Levels of serum creatinine and proteinuria are at the approximate time of the
renal biopsy. Nephrotic syndrome is defined as proteinuria ≥3.5 g/24 hours with
edema; in eight of the ten patients meeting these criteria, serum albumin levels
were known and ranged from 1.1 to 2.5 mg/dL. Weakly positive antinuclear
antibodies are defined as a titer of ≤1:80. HIV is human immunodeficiency virus
and IVDA is intravenous drug abuse.
anti-Ro and anti-La were also negative. Serum C3 was
low in four of nine patients in which this was examined.
Six of 12 patients tested had positive hepatitis C serol-
ogy (Table 2), although none had documented cryo-
globulinemia. As hepatitis C and HIV coinfection has
been found to be associated with immune complex-
mediated glomerulonephritis [7, 8], we compared clinical
and demographic data in the six hepatitis C–positive pa-
tients with that in the six patients known to be hepatitis
C–negative (Table 3). Although there were some minor
differences among these two groups of patients, includ-
ing a higher mean level of proteinuria in the hepatitis
C–positive cohort, none of these differences were statis-
tically significant.
Histologic findings from the 14 renal biopsies are sum-
marized in Table 4, with examples shown in Figure 1.
These histologic data are also subclassified according to
the patients’ hepatitis C status. Seven of the biopsies
showed diffuse proliferative glomerulonephritis with en-
docapillary cell proliferation in the majority of glomeruli,
exclusive of globally sclerotic glomeruli. In two of these
biopsies, including that represented in Figure 1A to C,
the glomerulonephritis had a pattern resembling MPGN,
type I, with diffusely hypercellular and hyperlobular
glomeruli and double contours of the glomerular base-
ment membranes on silver stain and on electron
microscopy, with multiple mesangial and subendothelial
immune complex deposits. One of the biopsies with this
pattern of glomerulonephritis (Fig. 1A to C) was from a
hepatitis C–positive patient, while the other was from a
hepatitis C–negative patient. One additional biopsy with
diffuse proliferative glomerulonephritis (Fig. 1D to F)
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Table 3. Demographic, clinical, and serologic features of patients




Age years (mean ± SD) 33.3 ± 11.8 (6) 36.8 ± 7.6 (6)
Age years, range 10 to 41 28 to 47
Gender male/female 4/2 4/2
Race African American/white 6/0 5/1
Known duration of HIV years
(mean ± SD)
11.7 ± 5.8 (6) 9.4 ± 7.8 (5)
Known duration of HIV years,
range
1 to 17 1 to 14
History of IVDA fraction (%) of
patients
4/5 (80%) 3/5 (60%)
Serum creatinine mg/dL (mean ±
SD)
4.0 ± 2.7 (6) 5.7 ± 3.7 (6)
Serum creatinine mg/dL, range 0.7 to 7.8 1.8 to 10.1
Proteinuria g/24 hours (mean ±
SD)
6.4 ± 3.5 (6) 4.4 ± 3.1 (6)
Proteinuria g/24 hours, range 0.5 to 9.5 1.2 to 9.0
Nephrotic syndrome fraction (%)
of patients
5/6 (83%) 3/6 (50%)
Hypertension fraction (%) of
patients




Hepatitis B surface antigen
fraction (%) positive
1/4 (25%) 0/6 (0%)
Serum C3 normal/decreased 3/1 2/2
Numbers in parentheses without percentages indicate numbers of patients.
Levels of serum creatinine and proteinuria are at the approximate time of the
renal biopsy. Nephrotic syndrome is defined as proteinuria ≥3.5 g/24 hours with
edema; in eight of the ten patients meeting these criteria, serum albumin levels
were known and ranged from 1.1 to 2.5 mg/dL. Weakly positive antinuclear
antibodies are defined as a titer of ≤1:80. None of the parameters listed were
significantly different in hepatitis C–positive and hepatitis C–negative patients
(P > 0.30 in all instances). HIV is human immunodeficiency virus and IVDA is
intravenous drug abuse.
showed crescents in 50% of the glomeruli present, with
focal and segmental “wire loops,” corresponding thick
capillary wall deposits on immunofluorescence and large
subendothelial deposits on electron microscopy. Six biop-
sies showed focal proliferative glomerulonephritis with
endocapillary proliferation in <50% of glomeruli. Three
of these biopsies, including that shown in Figure 1G to
I, showed concurrent HIVAN, and each of the three
corresponding patients presented with nephrotic syn-
drome and proteinuria of >6.0 g/24 hours. One biopsy
(Fig. 1J to L) showed membranous nephropathy re-
sembling membranous (WHO class V) lupus nephritis.
Glomeruli were normocellular, although immunofluores-
cence showed mesangial as well as glomerular capillary
wall staining and electron microscopy showed mesangial
and rare subendothelial deposits (the latter not present
in Fig. 1L) in addition to more numerous subepithelial
and intramembranous deposits. There was a trend to-
ward a difference in the distribution of histologic patterns
of glomerulonephritis between hepatitis C–positive and
hepatitis C–negative patients (Table 4), although this did
not reach statistical significance in this relatively small
sample of cases (P = 0.07).
A prominent feature of most of these biopsies was the
presence of moderate or severe tubular atrophy and inter-
stitial fibrosis (Table 4). Five biopsies, all but one from pa-
tients without concurrent HIVAN, showed focally severe
interstitial inflammation not limited to scarred areas of
the insterstitum, with focal clusters of eosinophils, sugges-
tive of possible drug-induced interstitial nephritis. None
of these five patients were on HAART at the time of the
biopsy and none of the biopsies showed granulomatous
inflammation, multinucleated giant cells, or crystals of
the type described in some patients taking indinavir [20].
Two biopsies, including that shown in Figure 1A, showed
focal changes of thrombotic microangiopathy, with very
focal fibrin thrombi and red blood cell fragments within
glomeruli and preglomerular arterioles.
Immunofluorescence and electron microscopy findings
from the 14 biopsies are summarized in Tables 5 and
6, respectively. The majority of biopsies showed at least
moderately intense (>1+) staining for all immunoglobu-
lins and complement components tested except for IgA,
which was only mildly positive (≤1+) in all but three biop-
sies. No significant differences were noted between hep-
atitis C–positive and hepatitis C–negative patients with
respect to the mean intensity of staining for any of the im-
mune reactants listed in Table 5 (data not shown). None
of the biopsies showed staining limited to the mesan-
gial areas for all immunoglobulins and complement com-
ponents. Likewise, all 12 biopsies examined by elec-
tron microscopy showed mesangial and subendothelial
electron-dense deposits, although the latter were rare in
the one case of membranous nephropathy. The majority
of cases showed subepithelial deposits as well. One biopsy
(Fig. 1H) showed focal immune complex deposits within
tubular basement membranes by both immunofluores-
cence (IgG, C3, and C1q) and electron microscopy.
All 12 biopsies on which electron microscopy was per-
formed showed TRIs within glomerular endothelial
cells.
Outcomes
Follow-up data were available for all of the 14 patients.
Two of the patients were dialysis-dependent at the time
of the biopsy and eight others subsequently developed
ESRD, all within 1 year of the biopsy. Three of the ten
patients who developed ESRD received HAART and
three received corticosteroids following the biopsy. Four
patients died from 3 to 12 months following the biopsy,
and all had ESRD at the time of death. Four patients
are alive with functioning kidneys. One, diagnosed as be-
ing HIV-positive during the year prior to the biopsy and
having no history of opportunistic infections, had mem-
branous nephropathy with moderate tubulointerstitial
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Table 4. Histologic findings in renal biopsies of patients with lupus-like glomerulonephritis
All cases (14) Hepatitis C–positive (6) Hepatitis C–negative (6)
Histologic pattern of glomerulonephritis number (%) of cases
Diffuse proliferative 7 (50%) 4 (67%) 1 (17%)a
Focal proliferative 6 (43%) 1 (17%) 5 (83%)
Membranous 1 (7%) 1 (17%) 0
Tubulointerstitial scarring number (%) of cases
Minimal (estimated <10% of cortex present) 0 0 0
Mild (estimated 10% to 24%) 2 (14%) 1 (17%) 1 (17%)
Moderate (estimated 25% to 49%) 5 (36%) 2 (33%) 1 (17%)
Severe (estimated ≥50%) 7 (50%) 3 (50%) 4 (67%)
Crescents (one or more) number (%) of cases 6 (43%) 2 (33%) 3 (50%)
Crescents in ≥50% of glomeruli number (%) of cases 1 (7%) 1 (17%) 0
Glomerular “wire loops” number (%) of cases 1 (7%) 1 (17%) 0
Concurrent HIVAN number (%) of cases 3 (21%) 1 (17%) 2 (33%)
Concurrent thrombotic microangiopathy number (%) of cases 2 (14%) 1 (17%) 1 (17%)
Possible concurrent int. nephritis number (%) of cases 5 (36%) 2 (33%) 2 (33%)
aP = 0.07 for the difference in distribution of histologic patterns of glomerulonephritis between hepatitis C–positive and hepatitis C–negative patients by chi-square
test. All other parameters were not significantly different (P > 0.30) between hepatitis C–positive and hepatitis C–negative patients. HIVAN is human immunodeficiency
virus (HIV)-associated nephropathy.
scarring (according to the criteria in Table 4), an ini-
tial serum creatinine of 1.4 mg/dL, nephrotic syndrome
with proteinuria of 9.5 g/24 hours, and mild hypertension.
He has been treated only with angiotensin-converting
enzyme (ACE) inhibitors and 10 months following the
biopsy continues to have nephrotic range proteinuria and
mild edema, with a serum creatinine of 1.7 mg/dL and
normal blood pressure. Another, also diagnosed as HIV-
positive within a year prior to the biopsy, had diffuse pro-
liferative glomerulonephritis with rare crescents, severe
tubulointerstitial scarring, probable drug-induced inter-
stitial nephritis (she was taking ibuprofen), and an ini-
tial serum creatinine of 3.3 mg/dL. She was treated with
prednisone for 3 months and discontinued the ibuprofen;
17 months following the biopsy her serum creatinine is
2.1 mg/dL. The two remaining patients, both with long-
standing HIV disease and AIDS, had biopsies showing fo-
cal proliferative glomerulonephritis (with rare crescents
in one) with mild or moderate tubulointerstitial scar-
ring. Their initial serum creatinine levels were 1.8 and
2.1 mg/dL, respectively. Both patients have been main-
tained on HAART; 43 and 42 months postbiopsy, respec-
tively, their serum creatinine levels are 1.5 and 1.3 mg/dL.
Notably, other than the patient with membranous
nephropathy, those patients who did not develop ESRD
had proteinuria below the nephrotic range (1.2, 1.3, and
3.0 g/24 hours), and none had edema at the time of biopsy.
By contrast, all but one of the patients who developed
ESRD had proteinuria of >5 g/24 hours and the nephrotic
syndrome, including the three patients whose biopsies
showed concurrent HIVAN.
Figure 2 illustrates renal survival for the cohort of 14
patients, based on Kaplan-Meier analysis, and Table 7
lists univariate associations between a number of clini-
cal and morphologic parameters and renal survival. Of
the parameters listed in Table 7, only the serum creati-
nine at the time of biopsy showed a significant associa-
tion with renal survival. However, if only cases of focal
and diffuse proliferative glomerulonephritis are consid-
ered (i.e., the single case of membranous nephropathy
is excluded), nephrotic range proteinuria and increasing
severity of tubulointerstitial scarring (see Methods sec-
tion) (see alsoTable 7 legend) each showed a borderline
significant (P = 0.04 and 0.05, respectively) negative as-
sociation with renal survival.
DISCUSSION
Lupus-like glomerulonephritis, defined by the pres-
ence of a “full house” of glomerular immunoglobulin
and complement deposits on immunofluorescence in the
absence of serologic evidence of SLE, was found in 14
of 77 (18%) native renal biopsies from HIV-positive pa-
tients processed at our center from January 1999 through
December 2003, making this second to HIVAN (present
in 37 biopsies, six with concurrent immune complex
glomerulonephritis) among the most common glomeru-
lar lesions in HIV-positive patients undergoing a renal
biopsy during this 5-year period. Our definition of lupus-
like glomerulonephritis is somewhat less limited than has
been used in some previous studies [2, 3], in that we did
not restrict this diagnosis to cases showing “wire loops” or
diffuse proliferative glomerulonephritis with prominent
subendothelial deposits on electron microscopy. This was
done because lupus nephritis itself may present with a
variety of histologic patterns [19], but with immune com-
plexes containing IgG, IgA, IgM, C3, and C1q being
common in each form, even “pure” membranous
nephropathy [21]. Our serologic criteria were designed
to prevent the inclusion of cases of true lupus nephritis,
which may occur in HIV-positive patients [13–17]. While
it is not uncommon for HIV-positive patients without
SLE to have circulating ANA, titers in these patients are
rarely >1:160, and anti-ds DNA is absent [22].
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Fig. 1. Light microscopic, immunofluores-
cence, and electron microscopic features
of four renal biopsies showing lupus-like
glomerulonephritis. (A to C) Diffuse pro-
liferative glomerulonephritis with a pattern
resembling membranoproliferative glomeru-
lonephritis, type I. The glomerulus (A) is en-
larged with global mesangial and endocapil-
lary hypercellularity, and appears mildly hy-
perlobular. There is partial occlusion of a pre-
glomerular arteriole by thrombus and rare
red blood cell fragments within the glomeru-
lar tuft (arrows), indicative of a thrombotic
microangiopathy. Immunofluorescence (B)
shows strong (3+ on a 0 to 4+ scale) mesangial
and segmental capillary wall staining for C3,
and electron microscopy (C) shows duplica-
tion of the glomerular basement membrane
(GBM) with subendothelial and mesangial
electron-dense deposits. (D to F) Diffuse pro-
liferative glomerulonephritis with crescents
and “wire loops.” The glomerulus (D) shows
a segmental cellular crescent; crescents were
seen in 50% of glomeruli on this biopsy. The
arrow indicates a severely thickened capillary
loop (“wire loop”). Immunofluorescence for
IgG (E) shows moderately intense (2+) stain-
ing in mesangial areas and capillary walls, with
some of the capillary wall staining appearing
thick, possibly corresponding to “wire loops.”
Electron microscopy (F) shows large mesan-
gial and subendothelial (bottom left) deposits.
(G to I) Focal proliferative glomerulonephri-
tis with superimposed human immunode-
ficiency virus (HIV)-associated nephropa-
thy (HIVAN). (G) The glomerulus at right
shows segmental endocapillary hypercellular-
ity (particularly in the upper left quadrant
of the glomerulus), while that at left shows
segmental collapse of the tuft with associated
swollen, hyperplastic podocytes (left portion
of glomerulus). Immunofluorescence for C1q
(H) shows mildly to moderately intense (1
to 2+) glomerular staining, mainly in capil-
lary walls, and weaker, finely granular stain-
ing in some tubular basement membranes.
Electron microscopy (I) shows subendothe-
lial deposits and duplication of the GBM. (J
to L) Membranous nephropathy. The rep-
resentative glomerulus in (J) is normocellu-
lar with a mild increase in mesangial matrix.
Immunofluorescence for IgA (K) shows 2+,
confluent granular staining in the glomeru-
lar capillary walls and mesangial areas. Elec-
tron microscopy (L) shows thickening of
the GBM with subepithelial and intramem-
branous deposits (arrows), with mesangial
deposits at the very top of the electron micro-
graph. This biopsy showed a moderate num-
ber of mesangial deposits and rare suben-
dothelial deposits, the latter not shown in this
panel. (A) Masson’s trichrome stain (original
magnification ×400). (B) Fluorescein isoth-
iocyanate (FITC)-conjugated antihuman C3
(×400). (C) Uranyl acetate and lead citrate
stain (×3000). (D) Hematoxylin and eosin
(×400). (E) FITC antihuman IgG (×400).
(F) Uranyl acetate and lead citrate (×5000).
(G) Silver methenamine (×200). (H) FITC
antihuman C1q (×400). (I) Uranyl acetate
and lead citrate (×3800). (J) Periodic acid-
Schiff (PAS) (×400). (K) FITC antihuman
IgA (×400). (L) Uranyl acetate and lead cit-
rate (×4000).
1388 Haas et al: Lupus-like glomerulonephritis in HIV-positive patients
Table 5. Immunofluorescence findings in renal biopsies of patients
with lupus-like glomerulonephritis
Staining Capillary
Immune intensity Number wall + Mesangial
reactant (mean ± SD)a (%) >1+ mesangial only
IgG 2.0 ± 0.8 12 (86%) 10 (71%)b 4 (29%)
IgA 1.1 ± 0.4 3 (21%) 9 (64%)b 5 (36%)
IgM 2.1 ± 0.6 13 (93%) 13 (93%) 1 (7%)
C3 2.3 ± 0.8 12 (86%) 12 (86%) 2 (14%)
C1q 1.4 ± 0.3 9 (64%) 10 (71%)b 4 (29%)
Kappa 1.6 ± 0.5 9 (64%) 14 (100%)b 0
Lambda 1.3 ± 0.4 6 (43%) 14 (100%)b 0
aStaining for each immune reactant was graded on a 0 to 4+ scale, in
increments of 0.5+. In addition to the glomerular staining noted in this table,
one biopsy showed focal, fine granular tubular basement membrane staining for
IgG, C3, and C1q (all 0.5+).
bIn one case, staining was limited to the capillary walls with minimal mesangial
staining.
Table 6. Electron microscopic findings in renal biopsies of patients
with lupus-like glomerulonephritis
Number (%)
Location of deposits of cases
Mesangial and subendothelial 3 (25%)
Mesangial, subendothelial, and subepithelial 4 (33%)
Mesangial, subendothelial, subepithelial, 5 (42%)
and intramembranous
Tubular basement membranes 1 (8%)
(in addition to glomeruli)
Tubuloreticular inclusions 12 (100%)
Electron microscopy was not performed in two cases as tissue processed for
electron microscopy did not contain glomeruli. None of the deposits present had
a specific substructure. The one biopsy that showed very focal, small tubular
basement membrane deposits by electron microscopy corresponded to that
showing focal tubular basement membrane staining by immunofluorescence (see
also Table 5 and Figure 1H).
It is of interest that 13 of our 14 patients with lupus-like
glomerulonephritis are African Americans. This would
appear consistent with the racial composition of the HIV-
positive population of the Baltimore metropolitan area
from which most of our HIV/AIDS patients are derived,
and is similar to the racial composition of all HIV-positive
patients undergoing a native renal biopsy at our cen-
ter from 1999 to 2003 (89% black among those 75 pa-
tients whose race is known). While European studies
have found that HIVAN is mainly limited to black pa-
tients and that most cases of glomerular disease in white
HIV-infected patients are immune complex-mediated [2,
3], it would appear from the present study and that
of Nochy et al [2], which showed lupus-like glomeru-
lonephritis in fairly similar fractions of black and white
HIV-positive patients undergoing a renal biopsy, that
lupus-like glomerulonephritis does not have a strong
predilection for individuals of either race.
Six of our patients were known to be hepatitis
C–positive, which raises the question of whether the
lupus-like glomerulonephritis in these patients may
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Fig. 2. Kaplan-Meier plot of renal survival from the time of the renal
biopsy for all 14 cases of lupus-like glomerulonephritis. Vertical hash
marks each indicate the end of follow-up for a patient who has not
developed end-stage renal disease (ESRD).
six hepatitis C–positive patients had diffuse proliferative
glomerulonephritis, one had focal proliferative glomeru-
lonephritis and one had membranous nephropathy; one
of the diffuse proliferative lesions had a MPGN-like pat-
tern. The histology of this latter case in particular, to-
gether with the reduced serum levels of C3 and C4 in this
patient, suggest a possible hepatitis C–related glomeru-
lonephritis. Arguing against this, however, is the fact that
none of the 16 cases of MPGN in patients coinfected
with hepatitis C and HIV reported by Cheng et al [7]
and Stokes et al [8] showed a “full house” of glomeru-
lar immunoglobulin and complement deposits with more
than equivocal or trace staining for all immune reactants.
Furthermore, of the 20 hepatitis C–positive patients (17
HIV-negative, three HIV-positive) diagnosed with non-
cryoglobulinemic MPGN type I or type III at our cen-
ter from 1999 through 2003, only two had a “full house”
of glomerular immunoglobulin and complement deposits
with more than equivocal or trace staining for all immune
reactants including C1q. By contrast, such staining was
observed in each of our six cases of lupus-like glomeru-
lonephritis in HIV- and hepatitis C–positive patients.
There is presently little information known about the
etiology of lupus-like glomerulonephritis, its treatment,
or its long-term outcome. HIV infection is associated with
polyclonal B cell activation, and circulating immune com-
plexes are commonly seen in HIV-infected patients [23,
24]. It is possible that deposition of such immune com-
plexes within glomeruli could play a pathogenic role in
mediating lupus-like glomerulonephritis and other forms
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Table 7. Univariate associations of clinical and morphologic
parameters with renal survival
Parameters Hazard ratio 95% CI P value
Age per year 1.01 0.94, 1.08 0.80
Gender
Female Reference
Male 1.01 0.28, 3.62 0.98
Duration of human 1.14 0.92, 1.41 0.24
immunodeficiency virus
per year
Serum creatinine mg/dL 1.32 1.09, 1.59 0.005
(all cases)




<3.5 g/24 hours Reference
≥3.5 g/24 hours 7.8 0.94, 65.3 0.06
Proteinuria (proliferative
glomerulonephritis only)
<3.5 g/24 hours Reference
≥3.5 g/24 hours 9.6 1.16, 79.3 0.04
Hepatitis C serology
Negative Reference
Positive 1.44 0.34, 6.17 0.62
Pattern of glomerulonephritis
Focal proliferative Reference
Diffuse proliferative 1.25 0.35, 4.50 0.73
Cellular/fibrocellular crescents
None Reference
≥1 0.89 0.25, 3.18 0.86
Tubulointerstitial scarring
(per 10%)
All cases 1.69 0.97, 2.90 0.07
Proliferative glomerulonephritis 1.71 1.00, 2.94 0.05
only
Analyses were performed using the Cox regression model. A hazard ratio
of >1.00 indicates an association with poorer renal survival; associations that
are statistically significant (P < 0.05) have their P values in boldface type. For
tubulointerstitial scarring, the hazard ratio shown is for each 10% increase in
the estimated fraction of renal cortex, exclusive of glomeruli and arteries, that is
occupied by sclerotic interstitium and atrophic tubules (see the Methods section).
of glomerulonephritis, such as IgA nephropathy, which
occur in HIV-infected patients. In support of this hypoth-
esis, Kimmel et al [6] described four HIV-positive pa-
tients with immune complex glomerulonephritis, which in
one case showed a “full house” pattern of immunoglob-
ulin and complement deposits within glomeruli by im-
munofluorescence. Each of these four patients had one or
more types of circulating immune complexes comprised
of IgG, IgA, and/or IgM antibodies and HIV antigens
(p24 and gp120), and both antibodies and HIV antigens
were eluted from the renal biopsies of these patients. At
least one of the antibodies identified, an IgG anti-p24,
was found to be complement-fixing [6].
Tabechian et al [18] reported a case of a 42-year-old
HIV-positive white man presenting with nephrotic syn-
drome, renal insufficiency, and negative lupus serologies,
who had two renal biopsies showing diffuse prolifera-
tive glomerulonephritis resembling WHO class IV lu-
pus nephritis. His renal function remained stable while
he received HAART, but rapidly deteriorated to ESRD
during an interval when HAART was discontinued and
his HIV viral load increased. There are additional case
reports of HIV-positive patients with immune complex-
mediated glomerular diseases showing reduction of
proteinuria following treatment with multidrug antiretro-
viral regimens [25, 26], although a recent multicenter
study failed to show a significant effect of antiretroviral
therapy on renal survival in HIV-positive patients with a
variety of glomerular lesions other than HIVAN, most im-
mune complex-mediated [27]. Five of our patients were
treated with HAART and two showed an improvement in
renal function that was stable 42 and 43 months after the
biopsy, respectively. The other three patients developed
ESRD within a year of the biopsy, although two of these
patients had very severe renal insufficiency (serum crea-
tinine >7 mg/dL) and nephrotic syndrome at the time of
their biopsies. Four additional patients were treated with
corticosteroids, which have been reported to be effica-
cious in treating some cases of HIVAN [28] and a case of
membranous nephropathy in a patient with AIDS [29].
One of these patients showed improved renal function
17 months postbiopsy, although this may be due primar-
ily to treatment of interstitial nephritis due to ibuprofen,
which was discontinued after the biopsy. The remaining
three patients developed ESRD within 3 months of the
biopsy; each had severe renal insufficiency (serum crea-
tinine >3 mg/dL) and nephrotic sydrome at the time of
biopsy.
Renal survival in our cohort of patients with lupus-like
glomerulonephritis was generally poor, and not dissimilar
to that in patients with HIV and hepatitis C–associated
MPGN or HIVAN whose renal biopsies showed at least
moderate interstitial fibrosis [7, 12]. In patients with col-
lapsing FSGS, including HIVAN, renal outcomes were
found to be significantly better in patients whose re-
nal biopsies showed <20% interstitial fibrosis than in
those whose biopsies showed >20% interstitial fibrosis
[12]. Similar findings have been reported for non-HIV–
infected patients with immune complex-mediated forms
of glomerulonephritis such as lupus nephritis [30, 31] and
IgA nephropathy [32–34]. By univariate analysis, and
considering only those 13 patients with focal or diffuse
proliferative glomerulonephritis, we found a borderline
significant negative correlation between the severity of
chronic tubulointerstitial change and renal survival in our
patients with lupus-like glomerulonephritis, although it
was not possible to perform a multivariate analysis of fac-
tors affecting renal survival because of the small patient
sample. Likewise, excluding the one patient with mem-
branous nephropathy, we found that nephrotic range pro-
teinuria was significantly and negatively correlated with
renal survival. This is not surprising, noting that heavy
proteinuria is well-documented as a negative prognostic
indicator for renal survival in other glomerular diseases
[31–37].
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CONCLUSION
Lupus-like glomerulonephritis is not an uncommon
form of glomerular disease in HIV-infected patients un-
dergoing a renal biopsy. This form of glomerulonephri-
tis may occur in African American or white individuals,
alone or concurrently with HIVAN. The clinical presen-
tation is most often nephrotic syndrome and renal in-
sufficiency, the latter often severe. Renal survival among
our patients with lupus-like glomerulonephritis was poor,
with ten of 14 patients developing ESRD, each within
1 year of his or her diagnostic renal biopsy. However,
whether this is truly representative of the complete spec-
trum of patients with lupus-like glomerulonephritis, and
whether this form of glomerulonephritis is responsive to
treatment with HAART and/or corticiosteroids, remain
to be determined as most of our patients already had ad-
vanced disease at the time of their renal biopsies.
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